
Locals looking for ways to protect Lake Winnipesaukee from harmful bacteria
In 2024, Winnipesaukee saw
Get N.H. Morning Report
A weekday newsletter delivering the N.H. news you need to know right to your inbox.
Enter Email
Sign Up
For some, the high levels served as a wake-up call about water quality issues threatening New Hampshire's largest lake, a beloved destination for locals and visitors alike and home to summer camps that families have attended for generations.
Advertisement
'This lake is the center of this region. It is the reason that people come here from all over the world,' said Manley, an owner of
Bob Manley of Meredith, N.H., is rowing across Lake Winnipesaukee in June to raise money for environmental conservation efforts.
David L. Ryan/Globe Staff
Lake Winnipesaukee contributes about $17 billion to the state's economy each year, according to
Advertisement
'I don't think you could stress enough how important it is for us to save this body of water,' said Manley. He is rowing to raise money for the
The organization has been tracking water quality at Winnipesaukee since the early 1980s. In that time, it has seen the levels of phosphorus increase and, with it, record-high levels of cyanobacteria blooms, according to Bree Rossiter, conservation program manager.
A view of Lake Winnipesaukee in Meredith.
David L. Ryan/Globe Staff
Cyanobacteria is a naturally occurring algae-like bacteria found in low levels in all of New Hampshire's lakes and ponds. It's one of the oldest living organisms on Earth, but when it grows quickly, it can be toxic, causing skin rashes, respiratory and gastrointestinal distress, and in rare cases, death to people
'In 2024, we had the most amount of cyanobacteria blooms that we've ever seen on Winni,' including in parts of the lake that typically don't harbor the potentially toxic blooms, Rossiter said.
Ice coverage on the lake has lessened in recent years, said Rossiter, noting that 2023 saw the shortest period of coverage since the 1800s. That has allowed sunlight, which helps cyanobacteria grow, to penetrate the lake earlier in the season. Intense rainstorms have created runoff flowing from lawns into the lake and bringing along nutrients that fuel the cyanobacteria's growth.
Leavitt Beach on Lake Winnipesaukee, which had been closed in 2024 for pollution.
David L. Ryan/Globe Staff
Thanks to climate change, the region is
Advertisement
'It's just kind of a recipe for disaster,' she said.
Meanwhile, phosphorus levels in the lake are about 300 percent higher now than they were prior to European settlement, according to the alliance's data. There's been an uptick over the past 10 years, Rossiter said, and phosphorus levels in the lake's water have grown to about six parts per billion. The more phosphorus in the water, the more algae and other plants can grow, often leading to murkier water.
Andrea LaMoreaux, president and policy advocate at NH Lakes, a nonprofit that works on lake preservation and restoration, warns that Lake Winnipesaukee is not alone in water quality issues. Around the state, she said, increased algae levels, decreased transparency, and large cyanobacteria blooms are signs that lakes are approaching a tipping point, where conditions could get much worse – and remediation could be significantly more difficult.
A gull on a dock piling at Lake Winnipesaukee.
David L. Ryan/Globe Staff
As lakes age, they naturally start filling in thanks in part to materials carried in by streams. The amount of plants growing in the water increases, and clear water becomes murkier. Over time, lakes turn into ponds, then marsh, until eventually they become meadows and, finally, dry land. But people are accelerating that process by adding more nutrients to lake water from sources like agriculture, fertilized lawns, and stormwater runoff, according to the
Since the 2000s, LaMoreaux said, cyanobacteria bloom sightings have been on the rise, a trend that's been accelerating in recent years.
'What's new is that last summer, Lake Winnipesaukee bloomed almost lakewide two times,' she said. 'I think that's what caught people's attention. . . . The big pristine lake all of a sudden is having cyanobacteria.'
Advertisement
Amanda McQuaid, director of the University of New Hampshire Lakes Lay Monitoring Program, said the tipping point for more algal growth and cyanobacteria typically happens when there's about 10 parts per billion of phosphorus in the water.
'Unfortunately, a lot of our lakes kind of dip in and out of that range,' she said. (The Lake Winnipesaukee Alliance is trying to limit phosphorus to no more than eight parts per billion in that lake.)
McQuaid said human development around lakes can contribute to the problem, pointing to the flurry of development after the COVID-19 pandemic. Impervious surfaces like roofs, parking lots, and driveways deflect water instead of allowing it to be absorbed into the ground, and the runoff carries nutrients into the water, feeding algae, bacteria, and plants. Leaky lakeside septic systems are another culprit.
Winnipesaukee is a highly developed lake, with private properties dotting much of the shoreline. That limits where the Lake Winnipesaukee Alliance can conduct mitigation projects.
Bob Manley rowed in Lake Winnipesaukee.
David L. Ryan/Globe Staff
But the alliance also works with property owners to provide recommendations about how to be more lake friendly, like getting their septic system pumped, avoiding fertilizers, or adding a buffer of native plants to their shoreline to filter polluted storm water runoff.
Still, the uptick in cyanobacteria blooms last summer disrupted small business on and around the lake.
Peggy Ames is the fifth generation innkeeper at Ames Farm Inn in Gilford, N.H. Last summer she had to explain to her guests why they couldn't swim in the lake.
Advertisement
She said that if the blooms continue, visitors could go elsewhere. 'People don't want to come up here and not be able to enjoy the water,' said Ames.
But, she said, the blooms caught people's attention, and it could push them to take action.
'It woke people up to knowing that this is a resource we do need to protect,' she said.
Amanda Gokee can be reached at

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Boston Globe
2 hours ago
- Boston Globe
Mass. EMS bills a first step to speed up ambulances and save lives
'The EMS system in our state is broken,' Feeley testified Wednesday at a hearing on the Legislature's Joint Committee on Public Health. 'Unfortunately, I witnessed its failures firsthand.' An EMT at the hearing teared up listening to Feeley's testimony during the hearing that addressed several pending bills related to local public health and emergency services. Advertisement Some municipalities, such as Boston, are large enough that they operate their own EMS services. However, around 80 percent of the state's licensed ambulances are operated by private companies that bid for the right to serve each town's population, the Globe Those private companies have not been able to hire and maintain adequate staff, which has led to ambulance delays, according to the Globe's coverage. The state also doesn't have a centralized system to coordinate ambulances and send them to another town in case of a shortage. A slate of bills intends to address the delays, most notably by designating EMS as an Advertisement Other legislation would set up a Other bills discussed at the hearing propose requiring that all 911 dispatchers in the state be trained to instruct people how to do CPR over the phone and creating a database that lists defibrillators across the state. The bill to make EMS an essential service proposes creating a fund to support EMS agencies and pay for things such as training, equipment, vehicles, and personnel salaries. Representative Leigh Davis, a Democrat of Great Barrington, who sponsored the bill said that for too long, EMS has been underfunded and is not always covered by patients' insurance. 'In 1973, the federal EMS Act left it up to the states to fund EMS, never recognizing it as an essential service,' Davis said. 'Unlike police and fire, there's no guaranteed funding, just donations, inconsistent local budgets, and low insurance reimbursement rates.' Mike Woronka, chief executive officer of Action Ambulance, a private company, said that as baby boomers retire, his company has found it difficult to fill EMS positions, making existing employees' jobs harder. 'We are beyond the crisis stage, it is affecting our staff, and it's affecting the residents of this Commonwealth,' Woronka said. Tina Dixson, an advanced EMT who has worked for 27 years in the Central Massachusetts towns of Hubbardston and Holden said she supports the bill to create a special commission on EMS. Advertisement 'If you pictured an EMT in a neatly pressed uniform, working … with the calmness and precision of a NASCAR pit crew, but with the bedside manner of Mr. Rogers, that isn't always the case,' Dixson said, 'We need a lot of assistance with some of the things in these bills.' Dixson also spoke in favor of bills creating a database for defibrillators so that people can locate one close to them in cases of emergency. Matt Zavadsky, a past president of the National Association of EMTs, said he supports the designation of EMS as an essential service, but noted the bill does not identify a funding source. Zavadsky said that it would be better for the state to designate EMS an essential service, and require localities to fund operations based on their own needs. 'Should the state set a standard that in rural areas in the Berkshires the response time should be 12 minutes?' Zavadsky said. 'And do they pick the provider they're going to contract with to provide that service? … It [should be] up to the local community to decide that.' For the bill proposing a pilot program for EMS workers to treat people 'in place,' Zavadsky said there needs to be an emphasis requiring insurers pay for treatment in place as opposed to only covering transportation to a hospital. 'Treatment in place is already proven, there's enough data out there to show that it's safe and it saves money,' he said. 'Payment models drive clinical practice, so we need the bill to require that insurers pay for treatment in place.' Angela Mathew can be reached at
Yahoo
6 hours ago
- Yahoo
Alberta reaches deal to donate imported children's pain medication to Ukraine
Alberta has reached a deal with a charitable organization to donate to Ukraine the province's surplus supply of children's pain medication it imported from Turkey two years ago in a deal that has become the subject of multiple investigations. Montreal-based Health Partners International of Canada (HPIC) told Postmedia on Tuesday that it had struck an agreement with Alberta Health Services (AHS) to accept as many as 1.4 million bottles of acetaminophen and ibuprofen to donate to the war-torn European country. The organization says once the donation is received, it will work with partner organizations and local government to identify where the supply is most needed. 'In essence we match what is needed to what we have available,' HIPC president Lois Brown stated in an email. 'Agreements with recipient partners include guarantees that all donated medicines will be used in accordance with applicable standard treatment guidelines.' HIPC partner organizations typically cover the costs of transportation for donated supplies. In April, Health Canada told Postmedia it had issued a 'no objection' letter in March to Alberta's request to donate the medication to Ukraine. The letter requires Alberta to ensure the drugs are only sold or donated abroad for humanitarian purposes, don't violate Ukrainian laws including import approvals, and that logistics and quality oversight are overseen by a compliant drug establishment licence holder. Turkish-base drug manufacturer Atabay had been seeking that licence though its status remains unclear. Postmedia's queries regarding the licence as well as details on quantity, timing, and cost were directed to the office of Hospital and Surgical Health Services Minister Matt Jones. AHS has previously said it was not part of the process of finalizing a donation agreement. The medication was imported in 2023 under exceptional circumstances amid a Canada-wide shortage, and is set to expire between January and March of next year, according to internal documents previously obtained by Postmedia. Less than a third of the planned shipment arrived, and much of the medication that did make it to Alberta went unused after the shortage ended. The imported acetaminophen proved unpopular due to its weaker dosage, and AHS told hospital staff to stop using the it six months after it arrived, in part because its thicker consistency posed a risk of clogging feeding tubes. The province's plan to recoup some costs by selling some of its supply to other provinces was abandoned amid unanimous lack of interest, and concern over its dosage, which is more common in Europe. Primary and Preventative Health Services Adriana LaGrange served as the health minister until mid-May when the province split the health portfolio into four new roles. In March, LaGrange described the medication as 'good quality drugs.' 'If we can't use them in Alberta, then we should be sending them to other countries,' she said. The $70-million deal in 2022 to bring in what was to be five million bottles of acetaminophen and ibuprofen has come under scrutiny following allegations of corruption by the former head of AHS regarding the procurement and contracting process. Those allegations have not been tested in court, and the government denies wrongdoing, but several inquiries into the deal are underway including the government's own investigation as well as others by the RCMP and Alberta's auditor general. As of last December, $49 million of the government's contract with Atabay remains unfulfilled, with the province seeking fulfill the balance by importing an intravenous adult pain medication. HIPC says it is the only Canadian charity licensed by Health Canada to handle donated medicines and has delivered more than $735 million in donated medicines and related supplies together with its partner organizations to over 130 countries since 1990. mblack@ Bookmark our website and support our journalism: Don't miss the news you need to know — add and to your bookmarks and sign up for our newsletters here. You can also support our journalism by becoming a digital subscriber. Subscribers gain unlimited access to The Edmonton Journal, Edmonton Sun, National Post and 13 other Canadian news sites. Support us by subscribing today: The Edmonton Journal | The Edmonton Sun.
Yahoo
8 hours ago
- Yahoo
The 5 Most Interesting Analyst Questions From GE HealthCare's Q1 Earnings Call
GE HealthCare's first quarter results came in above Wall Street expectations, as the company delivered broad-based revenue growth across all business segments. Management credited strong U.S. demand for imaging equipment—particularly in cardiology and oncology—as well as robust order activity and backlog expansion, for the positive momentum. CEO Peter Arduini highlighted, 'Record double-digit orders growth as a standalone company was driven by strength in the U.S. market, where we see customers prioritizing investments in imaging products.' The company also noted early market share gains and strong customer engagement as key contributors to the quarter's performance. Is now the time to buy GEHC? Find out in our full research report (it's free). Revenue: $4.78 billion vs analyst estimates of $4.66 billion (2.8% year-on-year growth, 2.5% beat) Adjusted EPS: $1.01 vs analyst estimates of $0.91 (10.6% beat) Adjusted EBITDA: $826.9 million vs analyst estimates of $794.4 million (17.3% margin, 4.1% beat) Management lowered its full-year Adjusted EPS guidance to $4 at the midpoint, a 14.5% decrease Operating Margin: 13.2%, up from 11.6% in the same quarter last year Organic Revenue rose 4.1% year on year (-0.5% in the same quarter last year) Market Capitalization: $32.96 billion While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Larry Biegelsen (Wells Fargo) asked about the timing and magnitude of tariff impacts and the pace of mitigation. CFO Jay Saccaro explained that most mitigation will be realized in the second half of the year and further improvements are targeted for 2026. Jason Bednar (Piper Sandler) inquired whether tariff mitigation actions were accelerated from long-range plans. CEO Peter Arduini clarified that while some actions were advanced, the broader margin and growth outlook remains unchanged. Vijay Kumar (Evercore ISI) questioned the proportion of tariff headwinds tied to U.S.-China trade and the potential upside if tariffs are eased. Saccaro detailed that bilateral tariffs account for the majority of the impact and that a rollback could deliver substantial upside to earnings. Robbie Marcus (JPMorgan) requested updates on Flyrcado's launch and potential anti-dumping risks in China. Arduini confirmed Flyrcado is on track and stated that recent anti-dumping investigations are not expected to materially impact the business. Joanne Wuensch (Citi) probed the durability of hospital capital spending and the timeline for photon counting CT approval. Saccaro reported continued strength in U.S. and European demand, while Arduini reiterated that photon counting CT remains on schedule for regulatory submission. In the coming quarters, the StockStory team will closely monitor (1) the pace and effectiveness of GE HealthCare's tariff mitigation strategies, (2) progress on new product rollouts, including Flyrcado and photon counting CT, and (3) sustainability of order growth and backlog conversion, particularly in key markets like China and the U.S. Updates on supply chain adjustments and the impact of shifting trade policy will also be important indicators of execution. GE HealthCare currently trades at $71.99, up from $68.09 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it's free). Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today. Erreur lors de la récupération des données Connectez-vous pour accéder à votre portefeuille Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données